Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Disease-free Survival After Resection Of Lung Metastases In Patients With Breast Cancer.

C. Ludwig, E. Stoelben, J. Hasse
Published 2003 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
AIMS Metastatic breast cancer is a systemic disease. The discussion concerning the resection of lung metastases in patients with breast cancer is controversial. METHODS Retrospective analysis of 25 patients with suspected pulmonary metastases operated between March 1989 and September 1998. Survival probabilities and disease-free survival was analysed using the Kaplan-Meier method and the log-rank test. RESULTS The median survival rate after resection of lung metastases for the 21 patients was 96.9 months. The disease-free survival (DFS) after resection of lung metastases was 27.6 months. Survival was not influenced by the receptor status, lymph node involvement, number of lung metastases (p=0.8) or the disease-free interval (DFI) (0.59). DFS was, however, influenced by the DFI. With a DFI of <2 years survival was 8.5 months, whereas with a DFI >2 years it was 36.1 months (p=0.012). The DFS was influenced, but not statistically significant, by the number of lung metastases (n=1/n>1). The median DFS was 28.8 months with one metastasis and 13.1 months with multiple metastases (p=0.29). CONCLUSIONS The indication to remove solitary lung metastases in patients with previous breast cancer is supported by these findings. Especially when the disease-free interval is greater than two years.
This paper references



This paper is referenced by
10.1056/NEJMCPC0805308
Case 30-2008
W. J. Gradishar (2009)
10.1007/s12282-011-0276-3
Improvement of survival and prospect of cure in patients with metastatic breast cancer
Y. Cheng (2011)
Survies à long terme plus de dix ans après exérèse chirurgicale d'une métastase pulmonaire de cancer du seir
C. Daniel (2006)
Pulmonary Metastasectomy Expert Consensus Statements
R. Bremner (2018)
10.1093/jnci/djq029
International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
O. Pagani (2010)
10.1007/978-3-319-48848-6_31
Surgery of Metastases in Stage IV Breast Cancer
E. Pennacchioli (2017)
10.1245/s10434-010-1016-1
Metastasectomy and Surgical Resection of the Primary Tumor in Patients With Stage IV Breast Cancer
Barbara A. Pockaj (2010)
10.1055/s-0043-108252
Lung Metastasectomy for Pulmonary Metastatic Breast Carcinoma.
S. Macherey (2017)
10.1245/s10434-017-6067-0
Surgical Outcomes of Isolated Malignant Pulmonary Nodules in Patients with a History of Breast Cancer
Zuodong Song (2017)
10.2147/BCTT.S71781
BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase
S. Larsén (2014)
10.1016/j.ctrv.2020.102114
Prognostic factors in patients with oligometastatic breast cancer - A systematic review.
A. van Ommen-Nijhof (2020)
10.1007/s10147-004-0472-7
Surgical treatment for metastatic malignancies. Pulmonary metastasis: indications and outcomes
H. Kondo (2004)
pacientes con cáncer de mama metastásico
H. Medina-Franco (2012)
Lung Metastasectomy for Pulmonary Metastatic Breast Carcinoma Lungenmetastasenchirurgie beim pulmonal metastasierten Mammakarzinom
Sascha Macherey (2017)
Lungenmetastasenchirurgie beim pulmonal metastasierten Mammakarzinom Lung Metastasectomy for Pulmonary Metastatic Breast Carcinoma
Autoren Sascha Macherey (2017)
10.3919/JJSA.76.1595
Ten Years Recurrence-free Survival after Pulmonary Metastasis of Breast Cancer Resected Surgically—Report of a Case—
Masahiro Uehara (2015)
10.1016/j.athoracsur.2012.11.043
Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer.
G. Meimarakis (2013)
10.3779/10.3779/J.ISSN.1009-3419.2015.04.06
Analysis of the Choice of Operation Mode and Prognosis Factors of Patients with Tumors of the Lung Metastasis
Y. Xu (2015)
10.5606/tgkdc.dergisi.2017.13770
Long-term outcomes and prognostic factors of pulmonary metastasectomy in breast cancer patients: a systematic review
A. Sourati (2017)
10.1200/JCO.2015.33.15_SUPPL.E12086
BP-C1 in treatment of patients with stage IV breast cancer: A randomized, double-blind, placebo-controlled multicenter study and additional open-label treatment phase.
S. Larsén (2015)
Surgery in metastatic breast cancer
J. Ruiterkamp (2012)
10.1002/ijc.33152
Clinical features and prognostic factors for extracranial oligometastatic breast cancer in China
B. Lan (2020)
10.1007/s12254-018-0426-9
Cure in metastatic breast cancer
T. Westphal (2018)
10.1007/s12282-013-0445-7
The discordance between primary breast cancer lesions and pulmonary metastatic lesions in expression of aldehyde dehydrogenase 1-positive cancer cells
T. Nogami (2013)
10.3779/j.issn.1009-3419.2014.03.18
肺部转移性肿瘤的临床诊治策略
M. Cai (2014)
10.1016/J.BREAST.2007.07.008
Breast surgery in advanced breast cancer: local control in the presence of metastases.
W. Wood (2007)
10.3978/j.issn.2072-1439.2015.08.10
Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis.
J. Fan (2015)
10.1016/j.athoracsur.2018.10.028
Expert Consensus Document on Pulmonary Metastasectomy.
J. Handy (2019)
10.1177/1010428317705082
The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis
S. Wu (2017)
10.2995/JACSURG.28.569
Examination of resection for pulmonary metastases of breast cancer
Hirotaka Mikagi (2014)
10.1007/s13402-018-0376-6
Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis
M. Yousefi (2018)
10.1016/j.thorsurg.2015.09.012
Results of Pulmonary Resection: Other Epithelial Malignancies.
S. Sponholz (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar